Abstract
Recent studies of the HapMap lymphoblastoid cell lines have identified large numbers of quantitative trait loci for gene expression (eQTLs). Reanalyzing these data using a novel Bayesian hierarchical model, we were able to create a surprisingly high-resolution map of the typical locations of sites that affect mRNA levels in cis. Strikingly, we found a strong enrichment of eQTLs in the 250 bp just upstream of the transcription end site (TES), in addition to an enrichment around the transcription start site (TSS). Most eQTLs lie either within genes or close to genes; for example, we estimate that only 5% of eQTLs lie more than 20 kb upstream of the TSS. After controlling for position effects, SNPs in exons are ∼2-fold more likely than SNPs in introns to be eQTLs. Our results suggest an important role for mRNA stability in determining steady-state mRNA levels, and highlight the potential of eQTL mapping as a high-resolution tool for studying the determinants of gene regulation.
Author Summary
Individual phenotypes within natural populations generally exhibit a large diversity resulting from a complex interplay of genes and environmental factors. Since the advent of molecular markers in the 1980s, quantitative genetics has made a significant step toward unraveling the genetic bases of such complex traits, in particular by developing sophisticated tools to map the genomic locations of genes that affect complex traits. These regions are known as quantitative trait loci (QTLs). More recently, these tools have been extended to the study of gene expression phenotypes on a massive scale. In this paper, we used a previously published dataset consisting of expression measurements of 11,446 genes in human cell lines derived from 210 unrelated human individuals that have been genetically characterized by the International HapMap Project. Our article develops and applies a framework for determining the genetic factors that impact gene regulation. We show that these factors cluster strongly near to the gene start and gene end and are enriched within the transcribed region. Our approach suggests a general framework for studying the genetic factors that affect variation in gene expression.
Introduction
Genetic variation that affects gene regulation plays an important role in the genetics of disease and adaptive evolution [1],[2],[3]. However, unlike protein-coding sequences, we still know little about how to identify the DNA sequence elements that control gene expression. It is still difficult to predict with any confidence which SNPs are likely to affect gene expression, without performing targeted experimental assays.
To address this gap, recent experimental and computational approaches have made progress on identifying elements that may be functional, for example through experimental methods that identify transcription factor binding sites [4],[5], by in vivo testing of possible enhancers [6] and by computational analysis of sequence data [7],[8],[9]. However, our understanding of the importance of different types of functional elements in gene regulation remains rudimentary.
As a complementary approach, genome-wide studies of gene expression are now starting to provide information on genetic variation that impacts gene expression levels [10]. Recent studies in a variety of organisms have shown that levels of gene expression are often highly heritable [11],[12],[13],[14], and that for many genes it is possible to map cis- and trans-acting factors using linkage [13],[15],[16],[17],[14] or association mapping [12],[18],[19],[20],[21]. Recent studies of experimental crosses in yeast and mice have used the locations of SNPs within eQTL genes to provide further information about the identity of functional elements [22],[23]. In studies of human lymphoblastoid cells, it has been reported that most strong signals of association lie within 100 kb of the transcribed region [12], and that eQTLs cluster roughly symmetrically around the TSS [20].
In this study, we applied a new Bayesian framework to identify and fine map human lymphoblast eQTLs on a genome-wide scale. In effect, we treat the SNP data as a tool for assaying the functional impact of individual nucleotide changes on gene regulation. Our analysis focuses on the impact of common SNPs on gene expression levels. By using naturally occurring variation, we test the effects of several million variable sites in a single data set. Our results provide a detailed characterization of the types of SNPs that affect gene expression in lymphoblast cell lines.
Results
We analyzed gene expression measurements from lymphoblastoid cell lines representing 210 unrelated individuals studied by the International HapMap Project [24],[25]. These expression data, first reported by [19], were generated using the Illumina Sentrix Human-6 Expression BeadChip. For each sample we also used SNP genotype data from the Phase II HapMap Project, consisting of 3.3 million genotypes per individual [25].
After remapping the Illumina probes onto human mRNA sequences from RefSeq, we created a cleaned set of expression data for 12,227 distinct autosomal genes that had a unique RNA sequence in RefSeq (see Methods). For most analyses we removed 634 genes that had one or more HapMap SNPs within the expression probe and 147 very large genes (>500 kb), leaving us with a core data set of 11,446 genes.
We then set out to identify SNPs that affect measured mRNA levels in cis. As an operational definition, we considered the “cis-candidate region” to start 500 kb upstream of the transcription start site (TSS) and to end 500 kb downstream of the transcription end site (TES). Consistent with previous work [20],[12], our preliminary analysis found that most detectable eQTLs lie within this region.
Although the HapMap samples represent four different populations, originating from Africa, Europe and east Asia, our main analyses pooled the data into a single sample. To avoid false positives due to population-level expression differences [26],[20],[27], for each gene we transformed the African, European and east Asian expression data separately to standard normal distributions prior to combining the samples (Methods). Our rationale for combining samples was that we should achieve better power and better localization of signals than if we analyzed the populations separately. In doing so, we assume that functional variants usually have similar effects in different populations, an assumption that is parsimonious, and has empirical support [20], Figure S1. The overall results for analyses of individual populations are very similar (see Figures S2, S3, and S4).
The Distribution of cis-Acting eQTLs
For each of the 11,446 genes, we tested for putative cis-acting eQTLs by regressing measured mRNA levels against SNP genotypes, independently for each SNP in the cis-candidate region, using a standard linear regression model. Consistent with previous reports [20], we found a substantial number of genes with strong evidence for containing at least one eQTL. A total of 744 genes (6.5%) had at least one SNP with a p-value <7×10−6. If the smallest p-value in each gene is treated as a summary statistic, this threshold yields a gene-level false discovery rate of 5% [28].
We also observed that, in many cases, the SNPs most strongly associated with mRNA levels for a particular gene lie in a restricted region, allowing relatively precise localisation of eQTLs. Figure 1 plots examples of p-values in three genes, illustrating both the strong association signal that is often achieved, and the relatively localised nature of many of the signals (Figure S5).
Encouraged by the potential for these data to localise eQTLs, we next examined the distribution of the physical location of putative eQTLs within the cis-candidate region. For each gene with an eQTL (defined as having at least one p-value <7×10−6) we took the position of the most significant SNP as an estimate of the location of the functional site. In practice, we expect that the most significant SNP will sometimes be the actual functional site, but usually it will not since (1) HapMap contains only ≈1/3 of common SNPs [25]; (2) some eQTLs may be due to SNPs in LD with nearby copy number variants, though in practice few of the copy number variants known to be associated with expression are well-tagged by SNPs in these data (data not shown; [19]); (3) a non-functional SNP in strong LD with the functional site may have a smaller p-value by chance. Using simulations we estimate that the median distance between the functional SNP and the most significant SNP in our data is 7.5 kb (Figures S6 and S7). As expected, local recombination rates are strongly inversely correlated with the distance between the functional SNP and the most significant SNP (Figure S8).
Figure 2 shows histograms of the locations of the most significant eQTL SNPs, as a function of gene size. (The plots incorporate a correction factor for the possibility of spurious signals due to undetected SNPs in the expression probes; see Methods.) Several interesting features emerge. First, the distribution of the most significant eQTL SNPs is roughly centered on the transcribed region. Second, nearly all such eQTL SNPs lie close to genes: we find relatively few that are >50 kb from the corresponding gene. Third, as shown in Figure S9, there is a significant enrichment of eQTL SNPs in exons compared to introns. We will return to this observation later in the paper.
Finally, for all three gene sizes, the highest density of eQTLs is around the TSS and immediately upstream of the TES, as reported previously in yeast [22]. The TSS peak was reported in a previous plot of these data [20], but in that previous analysis the TES signal peak was concealed due to the variability of gene lengths (see Figure S10). The TES signal is quite asymmetric: among genes with an eQTL, 10% (75) have the most significant eQTL in the 4 kb upstream of the TES, compared with just 4% (29) in the 4 kb immediately downstream.
A Hierarchical Model of eQTLs in the cis-Candidate Region
While Figure 2 reveals the broad distribution of eQTLs and makes few modeling assumptions, it does not easily enable formal model testing about which aspects of gene structure (or other sequence features) are most important for generating eQTLs. Moreover, since the most significant SNP is not always close to the functional site, this approach can be expected to flatten out the true peaks of eQTLs and to increase the numbers of eQTLs that appear to lie far from the target genes.
Consequently, we next developed a Bayesian hierarchical modeling approach that solves many of these problems (see the Methods for further details). We considered a collection of models in which the parameters predict the prior probability that any given SNP in the cis-candidate region will be an “eQTN” (i.e., the functional nucleotide that creates an eQTL). Each model incorporates information about the physical locations of SNPs and, in some of our models, additional functional annotation of the SNPs. (Our calculations assume that the actual functional site is included in the HapMap genotype data; see below for further discussion.) The model parameters are estimated by maximizing the overall likelihood of the expression data, across all genes.
To implement our hierarchical approach, we switched to using Bayesian regression to test for association between SNPs and gene expression [29] (Methods). For each SNP in the cis-candidate region around a gene, we computed a Bayes factor that measures the relative support for the alternative hypothesis (the SNP is an eQTN) compared against the null (the SNP is independent of gene expression). For these data, the Bayes factors are highly correlated with p-values from standard linear regression. However, a key advantage of Bayes factors is that, combined with the prior probabilities specified by the model, they allow us to compute the posterior probability that each SNP is the actual eQTN.
The hierarchical model shares information across all genes about the distribution of signals and this in turn allows better weighting of which SNPs in individual genes are most likely to be eQTNs. For example, consider a hypothetical gene in which two SNPs that are associated with expression are in perfect LD (r 2 = 1). Suppose that one SNP is very close to the TSS, and the other is 30 kb upstream. In the p-value analysis, we would assign each of these SNPs 50% weight. In contrast, the hierarchical model downweights the upstream SNP because it is apparent from the overall data that eQTNs are much more abundant near the TSS, suggesting that the SNP near the TSS is much more likely to be responsible for the signal. Simulations show that the hierarchical model provides a more accurate profile of the distribution of eQTNs (see Figures S5 and S11).
Of course, some degree of complication is added by the fact that current HapMap data do not yet contain all SNPs. Therefore, the sites that we infer to be “eQTNs” in this study surely include many SNPs that are tags of nearby functional SNPs that are not in HapMap. This effect will systematically reduce our estimates of the importance of any particular factor in predicting eQTNs. In the case of factors relating to physical location (such as distance from the TSS) simulations show that this has a modest impact on spreading out the signal peaks that we observe, and that the overall distribution of signals is still estimated very well (see Figure S5, S11, and S12). In contrast, in the case of factors relating to functional categories (e.g., whether a SNP lies in a conserved element) we would expect the impact to be much more serious since functional elements are usually small and tag SNPs are unlikely to fall within the same element as a functional site. A second complication is caused by the possibility that undetected SNPs in the expression array probes might create spurious signals [30]. Our hierarchical model includes an explicit correction for this, using the 634 genes with a known SNP in the probe as training data.
Distribution of eQTNs with Respect to the Transcribed Region
We first set out to get a more refined view of the distribution of eQTNs across the cis-candidate region. The basic versions of our hierarchical model described the positions of SNPs relative to a single “anchor” point such as the TSS. SNPs were grouped into discrete bins based on their distance upstream of the anchor, or downstream (treated separately). The bins nearest the anchor point were just 1 kb wide, to accommodate rapid changes in the rate of eQTNs, while more distant bins were wider (this improves the parameter estimates since the distant bins generally contain few eQTNs). Each bin was associated with a single parameter that relates to the proportion of SNPs in that bin that are eQTNs. The rationale for this model was that it would provide a good description of the data if, for example, the abundance of regulatory elements could be well predicted by distance from the TSS alone.
We also considered models with pairs of anchor points (e.g., the TSS and the TES). In those models, each SNP belonged to two bins, each corresponding to the distance from one anchor point. This model treats the probability that a SNP is an eQTN as the sum of an effect due to the first anchor plus an effect due to the second anchor. Recall that our gene set includes only genes with a single annotated transcript, so that this analysis does not incorporate alternative transcription start or end sites.
Table 1 compares eight different models using either a single anchor point (e.g., TSS or TES), or pairs of anchors (TSS and one other anchor). We used AIC (Akaike Information Criterion) to penalize the two-anchor models for the extra parameters that they use.
Table 1. Candidate models of eQTN locations, ranked by AIC.
Model | Log Likelihood Diff. | AIC Difference |
TSS+TES | 0.0 | 0.0 |
TSS+CDSE | −11.9 | −11.9 |
TSS+Probe | −14.8 | −14.8 |
TSS+TXMID | −58.5 | −58.5 |
TSS+CDSMID | −63.5 | −63.5 |
TSS | −117.8 | −66.8 |
TSS+CDSS | −94.9 | −94.9 |
TES | −330.7 | −229.7 |
The table compares the performance of seven different hierarchical models of eQTN locations. In each model we used either a single “anchor” point to predict the locations of eQTNs (e.g., the location of the TSS) or two anchor points (e.g., the TSS and TES locations). The “TSS+CDSE” model uses the TSS and the coding sequence end locations as anchors; similarly “probe” refers to the location of the probe and “TXMID” is the midpoint of the transcript. The second and third columns compare the model listed on that line against the best model (TSS+TES), in terms of the difference in log likelihood (column 2) and the difference in Akaike Information Criterion (AIC, column 3). AIC penalizes the two-anchor models for 51 additional parameters compared to the one-anchor models.
In summary, the results provide compelling support for a model including both the TSS and TES over all other models (Table 1). Two other two-anchor models (namely TSS+probe location, and TSS+coding sequence end) also performed well, presumably because the Illumina probes and the coding sequence end positions are usually near to the TES. However, given that the TSS+TES model had by far the strongest support, we use this model in our subsequent analyses.
We next replotted the locations of eQTNs, using the posterior probabilities estimated by the hierarchical model (Figure 3). Compared to the p-value-based analysis, the two strong peaks of signal near the TSS and TES are considerably strengthened. Also, in the hierarchical model, the level of background signal upstream and downstream of the gene is greatly reduced, presumably because most of the background signal in the p-value analysis can be explained as resulting from LD with SNPs near the TSS and TES. The hierarchical model estimates that the total number of eQTLs is considerably larger than the number that we detected by linear regression at the rather stringent false discovery rate of 5% (1586 vs. 744). This difference is partly because the hierarchical model adds fractional probabilities for eQTLs that have only partial support for being true eQTLs, and partly because the hierarchical model is more sensitive to signals in locations that are likely a priori.
Another view of the hierarchical model results is shown in the cumulative plots in Figure 3, which plot the cumulative distribution of eQTNs across the gene region. Most eQTNs lie close to the gene, with less than 7% of the detected cis-eQTNs located more than 20 kb outside the gene. Overall, there are about 3-fold more eQTNs in the upstream region of the gene (5′ of the TSS) than downstream (3′ of the TES) (30% vs. 9%).
We next investigated the peaks of signal near the TSS and TES in more detail, using a finer bin partition close to the TSS and TES (see Figure 4A and Methods). At this finer scale, the TES signal is extremely sharply peaked over a region of just ∼100 bp immediately upstream of the TES. The data strongly reject a model in which the signal is symmetric around the TES (p = 3×10−7). In contrast, the TSS signal is more spread out, and spans both sides of the TSS. There is no evidence of asymmetry in the TSS signal (p = 0.34).
We also observed that the TSS and TES peaks both correspond with two parts of the typical gene structure that, averaging across all 11,446 genes, tend to be highly conserved across the mammalian phylogeny (Figure 4B). The correspondence of the two eQTN peaks with the peaks of conservation suggests that there may be a causal link between these two types of signals. We propose that the sequence conservation reflects, at least in part, the roles of these two locations in regulating mRNA levels, though further work will be needed to verify the connection.
Similarly, the TSS peak also matches up closely with the peak binding densities of a collection of transcription factors that are involved in transcription initiation (reported previously by the ENCODE group, based on ChIP-chip data collected for a set of regions spanning ∼1% of the genome [4]). As might be expected, the ENCODE data identified almost no transcription factor binding near the TES. We return to these latter observations in the Discussion.
Distribution of eQTNs with Respect to Functional Annotation
We next used our hierarchical model to examine the impact of various types of functional annotation on the probability that a SNP is an eQTN. We first classified SNPs that lie inside genes into categories based on the exon/intron structure (e.g, first, coding and last exons; first, internal, and last introns; Figure S13). In order to make the model fully identifiable, we estimate the effect of each annotation relative to the abundance of eQTNs in internal introns (as this category has the greatest number of SNPs). Since gene position is highly predictive of eQTN abundance, we controlled for SNP position using the TSS+TES model. In effect, the hierarchical model now tests whether the annotation adds any predictive value beyond the basic position information. As noted above, incomplete SNP ascertainment in HapMap means that we will generally underestimate–perhaps substantially–the impact of relevant annotations.
The main result of this first analysis is that internal introns have a deficit of eQTNs, compared to coding exons, as well as first and last exons and introns (Figure 5, Table S1). For example, SNPs in coding exons are ∼2-fold more likely than SNPs in internal introns to be eQTNs. First introns are also relatively enriched for eQTNs compared to internal introns (controlling for position). However, since the total amount of sequence contained in introns vastly exceeds that in exons, 53% of genic eQTNs lie in internal introns compared to 10% in coding exons (see Table S1). SNP density differs slightly between exons and introns, but not nearly enough to generate a 2-fold difference in eQTN abundance (Table S2). Overall, the hierarchical model that includes the gene structure annotation as well as position effects relative to the TSS and TES is substantially better than the TSS+TES-only model (by 7 units of AIC).
We then considered the impact of a variety of other types of SNP annotation (see Methods and Figure S14). None of these annotations shows convincing signals of enrichment (Table S3). We estimate a 1.9-fold enrichment of eQTNs inside conserved noncoding elements, as might be expected if these identify functional elements, however the 95% confidence interval narrowly overlaps 1. We also tested for an enrichment of eQTNs at computationally predicted microRNA binding sites, reasoning that SNPs in these binding sites might affect mRNA degradation. We found a suggestive, but non-significant, enrichment of eQTNs in these sites (1.4-fold). It is unclear whether the absence of significant effects in these analyses indicates that these types of annotation are not strongly associated with eQTNs or instead reflects the incompleteness of HapMap and the limitations of current functional annotations.
Finally, based on ENCODE results showing that the promoter regions of genes with CpG islands tend to have more accessible chromatin and greater occupancy by transcription factors [4], we predicted that CpG status might also provide relevant annotation. Indeed, we find that genes with a CpG island spanning the TSS are expressed at higher average levels, and are ∼50% more likely than genes without a CpG island on the TSS to have a cis-eQTN (15% vs 11%). This effect is consistent with the observation that genes with CpG islands are more likely to be expressed in a wide range of tissues than are genes without CpG islands [31]. After adjusting for the different overall rates of eQTNs, the distribution of signal locations in the two classes of genes is very similar (Figure S15).
Discussion
Cells use a variety of mechanisms at the transcriptional and translational levels to regulate gene expression. Transcription initiation is controlled by the interaction between transcription factors and cofactors with a set of cis-acting regulatory elements including core and proximal promoters that lie close to the TSS, as well as enhancers, silencers and boundary elements that may act at a distance [32],[33],[34],[35]. Initiation is also affected by epigenetic properties of the DNA such as chromatin condensation and DNA methylation. After transcription initiation, mRNA levels can also be regulated during mRNA elongation or splicing and by mRNA stability and degradation. However, for most genes, transcription initiation is usually thought to be the principal determinant of the overall mRNA gene expression profile [34],[35].
Consistent with the importance of transcription initiation, we found a strong peak of eQTNs near the TSS, with 33% of eQTNs lying within 10 kb of the TSS. Many of these eQTNs are likely to be polymorphisms that change the binding strength of transcription factor binding sites, thereby affecting the rate of transcription [22]. We also found that eQTNs are distributed roughly symmetrically around the TSS, with the peak density in ∼1 kb on either side (c.f. [20]). Our results at the TSS are consistent with recent observations by the ENCODE team that the peak density of transcription factor binding is centered on the TSS (Figure 4C). These observations indicate that empirical scans for regulatory variants that only look upstream of the core promoter [e.g., 13],[36] may often miss important sites of regulation.
In addition to the peak of eQTN signals near the TSS, we were intrigued to find a second, similarly strong peak near the TES, as seen previously in yeast [22]. This peak is more concentrated than the TSS peak, localizing immediately before the TES, and dropping extremely rapidly after the TES. We also found that, after controlling for position effects, SNPs in exons are consistently more likely than SNPs in internal introns to be eQTNs. These observations suggest that an important fraction of eQTNs may affect properties of the transcript, rather than of the DNA sequence. We hypothesize that these eQTNs are typically polymorphisms that affect transcript stability or the rate of transcript degradation [37],[38],[39],[40],[41]. In contrast to transcription initiation, mRNA stability has been less widely studied and we still have an incomplete picture of the mechanisms that determine transcript persistence. One such mechanism is the hybridization of microRNAs to single strand transcripts, thereby exposing them as targets for degradation. Hence a SNP that creates or disrupts a match between a microRNA and the transcript might affect the rate of degradation [40]; however we did not find a significant enrichment of eQTNs in predicted microRNA binding sites.
An alternative explanation for the overrepresentation of eQTNs in exons is that in some cases these may cause alternative splicing of the exon containing the expression probe, thereby changing measured expression levels. In particular, SNPs in the last exon might sometimes affect the location of the TES [21], perhaps even deleting the expression probe from the transcript. While this mechanism probably accounts for some of the data, we do not believe it is the main explanation for several reasons. First, we found that the TSS+TES model was significantly better than the TSS+probe model. If the effect was mainly due to SNPs that affect alternative splicing of the exon containing the probe, we anticipate that those SNPs would usually lie nearer to the probe than to the TES. In that case the TSS+probe model should have performed best. Second, in a separate analysis, we observed an enrichment of signals near the TES in Affymetrix exon array data when we combined data across probes from multiple exons (results not shown, data from [21]). Third, the striking peak of sequence conservation near the TES (Figure 4B) indicates that this is a region with strong functional significance, presumably due to an important role in gene regulation.
Our results also imply that surprisingly few eQTNs with large effects lie far upstream of the TSS (or downstream of the TES): for example, just 5% of the eQTNs that we detected were more than 20 kb upstream of the TSS. These results are consistent with data showing that most transcription factor binding sites are near the TSS [4]. However, since our method focuses on the major eQTN in each gene, we may under-estimate the abundance of distant eQTNs if these typically have smaller effect sizes ([12]). By focusing on SNPs, our analysis may miss the impact of other types of variation–such as copy number variation–that might plausibly exert effects over different physical scales. It is also possible that more distant elements are less likely to be disrupted by single nucleotide changes. Finally, it will be important to revisit the questions that we considered here in a range of other tissues. By studying cell lines, we may underestimate the importance of long-range enhancers that turn genes on or off depending on conditions outside the cell (e.g., during development).
In summary, our results show that eQTL studies provide a remarkably high-resolution tool for identifying variants that affect gene expression. A major strength of the eQTL approach is that, unlike other experimental techniques that are more targeted, the eQTL approach is agnostic about the mechanism of action of the functional variants, provided only that they are encoded in the DNA sequence (as opposed to epigenetic factors, for example). Hence, eQTL studies can provide a relatively unbiased view of the importance of different types of regulatory mechanisms. Moreover, as the cost of genome sequencing drops, it will soon be possible to conduct these analyses with nearly complete ascertainment of variation, potentially providing this approach with the resolution to study the sequence level determinants of gene expression. We anticipate that eQTL mapping will make an essential contribution to our understanding of human gene regulation.
Methods
Genotype Data
We analyzed genotype and expression data from 210 unrelated individuals studied by the International HapMap project [24],[25]. These include 60 Yoruba (YRI) and 60 CEPH (CEU) parents, and 45 unrelated Chinese (CHB) and 45 unrelated Japanese (JPT) individuals. We used the HapMap Phase II genotype data, release #21 (phased and with missing data imputed). We used data from the 22 autosomal chromosomes only, giving a total of 3,304,587 SNPs. Since allele frequencies in CHB and JPT are extremely similar [24], these two samples were treated as a single analysis panel of 90 Asians (“ASN”).
Gene Expression Data
We used gene expression levels that were measured previously in lymphoblastoid cell lines from all 210 unrelated individuals, using Illumina's human whole-genome expression array (WG-6 version 1) [19]. We downloaded the data that were normalized first by quantile normalization within replicates and then median normalized across all HapMap individuals [19] [ ftp://ftp.sanger.ac.uk/pub/genevar/].
Since mean expression levels at many loci differ between the HapMap populations [26],[42],[20],[27], there is a potential for spurious eQTLs in the combined sample due to population structure. To control for this effect, we applied a normal quantile transformation to the data for each gene, within each HapMap population (ASN, CEU, YRI), prior to combining the samples. That is, for each gene, separately in each population, we transformed the rth largest gene expression value to the (r−0.5)/nth quantile of the standard normal distribution, where n is the number of individuals with gene expression data from that population [29]. By forcing each population to have the same distribution of expression values, we avoid concerns about spurious associations due to allele frequency differences between the HapMap populations. (Note that the overall results within populations are very similar; Figures S2, S3, and S4.) This normalization also reduces the effect of outlying expression values on the regression [29].
Selection of Genes and Probes
We used BLAT [43] to map the 47,294 Illumina array probes onto human RNA sequences from RefSeq (hg18) [44]. The accession numbers of the RNA sequences were mapped against the Entrez Gene database and all probes that mapped with greater than 90% identity to multiple genes were discarded. Of the remaining probes we retained only those with exact matches to a unique gene, leaving us with 19,536 valid probes. Of these, we kept the 13,244 probes for which the gene has a single RNA accession in the RefSeq database. This was done to simplify the analysis by avoiding genes with multiple splice forms or multiple annotated start sites, etc. These 13,244 probes map to 12,227 unique autosomal genes.
Of these 12,277 genes, 85% contained exactly one probe. For the genes with multiple probes, we analyzed only a single probe, selecting the probe nearest to the 5′ end of the gene. We selected this probe because overall the probes are strongly biased towards the 3′ end of the gene, and we wanted to reduce this bias as far as possible. Then, we removed 634 genes for which there was at least one HapMap SNP inside the probe since it is known that such SNPs can impact the measured expression level [30]. Finally, 147 very large genes (size greater than 500 kb) were discarded, leaving our core data set of 11,446 genes.
Gene Structure and SNP Annotation
Gene structure annotation was obtained from the RefSeq gene table [44] for human genome build 35 (hg17). For each gene the TSS and the TES genomic locations were obtained from the fields “Transcription start position” and “Transcription end position” of the RefSeq table, respectively. We checked the genomic positions of the TSSs against dbTSS, a database of experimentally-determined TSSs, [45] and found no differences among the 84% of gene transcripts in our data set that are also in dbTSS. We defined the CDS (coding sequence) to be everything between the translation start and stop positions defined by the fields “cdsStart” and “cdsEnd”, respectively, of the RefSeq Table. We then assigned every genic SNP to one of 8 mutually exclusive gene-related annotations (see Figure S16):
First (non-coding) exon. If the gene has at least 2 exons, this is the part of the first exon that is not located inside the CDS. If the gene has only one exon, we do not consider it to have a first exon.
First intron. If the gene has at least 2 exons, this the intron following the first exon, provided that it is not located inside the CDS. Otherwise there is no first intron.
Noncoding exon. This is any part of an exon located outside the CDS region and excluding the first and last exons.
External intron. This is an intron located outside the CDS region and excluding the first and the last introns.
Coding exon. This is any part of an exon located inside the CDS region. Note that exons containing the translation start or stop generally contain both coding exon and noncoding (or first/last) exon. Coding SNPs were further subdivided into synonymous and nonsynonymous, according to their annotation in dbSNP.
Internal intron. This is an intron located inside the CDS region.
Last intron. If the gene has at least 2 exons, this is the intron preceding the last exon, provided that it is not located inside the CDS. Otherwise there is no last intron.
Last (noncoding) exon. If the gene has at least 2 exons, this is the part of the last exon that is not located inside the CDS. Otherwise there is no last exon.
We also included annotations that indicate whether a SNP is in the following special categories: SNP is in a (1) CpG island; (2) conserved noncoding region; (3) predicted cis-regulatory module; (4) predicted micro-RNA binding site; or that (5) a predicted binding site of the CTCF insulator protein lies between the SNP and the TSS. See the Supplementary Methods (Text S1) for further details.
Finally, note that in our analysis design, each SNP is tested for association with every gene that is within 500 kb. This means that typical SNPs contribute data to multiple genes. Our analysis treats these multiple tests as independent, which is likely a good approximation since we identified only five SNPs that are eQTLs for > one gene in cis.
Statistical Analysis
Notation
The data consist of SNP genotypes and gene expression measurements for n individuals at each of K genes. Let yik denote the normalized gene expression data for individual i (i in 1,…, n) at gene k (k in 1,…, K). Yk will denote the vector of gene expression values (y.k) across the n individuals at gene k.
Next, let Mk be the number of genotyped SNPs in the cis-candidate region of gene k. We denote the entire matrix of genotype data for these Mk SNPs with the vector Gk, and individual genotypes as gijk for individual i at SNP j of gene k. Genotypes are coded as having 0, 1, or 2 copies of the minor allele.
P-Value Method
In the first part of the paper we used standard linear regression to test the gene expression data at each gene for association with SNPs in the cis-candidate region, as follows. The effect of individual i's genotype at SNP j (gijk) on his/her gene expression level (yik) is assumed to follow an additive linear model:
(1) |
where μ is the mean expression level at that gene for individuals with g = 0, where ajk is the additive effect of the minor allele at SNP j and εijk is the residual. A standard p-value from a 1 df test can then be obtained for the hypothesis that SNP j is an eQTN for gene k (ajk ≠ 0).
We used the following procedure to generate the results plotted in Figure 2. For each gene with expression data we assigned each SNP in the cis-candidate region to a single bin (see below). Let m be the total number of SNPs that fall into bin b, summing across all genes. (Note that most SNPs are in the cis-candidate regions of multiple genes and hence can contribute data to multiple bins.) Next, for each gene, we tested every SNP for association with gene expression. If the p-value of the most significant SNP was <7×10−6 then we considered this to be one “signal” in the bin that this SNP lies in. (Note that the results are robust to the choice of the p-value cutoff; Figures S17 and S18.) For genes in which the smallest p-value was shared by n>1 SNPs, we considered that the signal was divided equally among the n most significant SNPs (i.e., a fraction 1/n of the signal was assigned to each SNP). Suppose that, by this way of counting, there are s signals in bin b.
Prior to reporting the data, we also applied a correction for the possibility of spurious signals due to ungenotyped SNPs in the expression array probe. We used the 634 genes with a known HapMap SNP inside the probe to create a profile of the abundance of spurious signals as a function of distance from the probe. This profile was used to adjust the observed number of signals, s, to a corrected number s′, that removes the predicted number of spurious signals in each bin (see Figure S19 and Text S1 for details). In practice, we estimate that the contribution of spurious signals does not substantially change the overall uncorrected distribution of signals. Finally, we computed the fraction of most significant SNPs in bin b as s′/m.
Bin Definitions
To display the distribution of signals in Figures 2 and the left panel of Figure 3 we subdivided the cis-candidate region into discrete bins as follows. First, since there is dramatic variation in gene sizes, we analyzed genes in three separate categories based on transcript length: small genes (0–20 kb), medium genes (20–100 kb) and large genes (100–500 kb). Then, within each gene size category we divided the entire cis-candidate region into a series of bins, anchored at the TSS and TES. SNPs outside the transcript were assigned to bins based on their distance from the TSS (for the upstream region) or TES (downstream). Bins outside the transcript were 1 kb wide for small and medium genes and 15 kb wide for large genes. Transcribed regions were split into fixed numbers of bins: each small gene was split into ten bins of equal size, medium genes into 25 bins and large genes into 15 bins. Hence, bins inside the transcript indicate the fractional location of SNPs relative to the TSS and TES, and the physical sizes of the bins vary across genes. The bin sizes were chosen so that the average physical sizes of internal and external bins are roughly the same within each gene size category.
Hierarchical Model
We present here an overview of the hierarchical model. Complete details on the models are provided in the Supplementary Methods section (Text S1).
Bayesian Regression Model
The hierarchical model applies the Bayesian regression framework of Servin and Stephens [29]. The effect of individual i's genotype at SNP j (gijk) on his/her gene expression level (yik) is assumed to follow a linear model:
(2) |
where μ is the mean expression level at that gene for individuals with g = 0, and where ajk and djk are the additive and dominance effects of the minor allele at SNP j. The residual, εijk, is assumed to be N(0,1/τ) and independent for each yik, where 1/τ is the variance of expression levels within each genotype class. The indicator function I(gijk = 1) is defined as 1 if the genotype is heterozygous (gijk = 1) and 0 otherwise.
Let denote the probability of the expression data Yk under the null hypothesis that there are no cis-eQTNs in gene k (i.e., ajk = djk = 0 for all j). Similarly, let denote the probability of the expression data Yk assuming that SNP j is the eQTN. In this case, the effect sizes ajk and djk are modeled as being drawn from mixtures of normal distributions centered on 0 (see Text S1 for details). The Bayes factor (BF) for SNP j in gene k is defined as
(3) |
and measures the relative support for the hypothesis that SNP j is an eQTN for gene k, versus the null hypothesis. We use priors on effect sizes that allow the BF to be calculated analytically (see Text S1).
The Hierarchical Model
We describe first the basic version of our hierarchical model. All the results presented in this paper additionally include a correction for the possibility that genes might show signals due to undetected SNPs in the probe. We describe that extension later in the Methods, briefly, and in detail in the Supplementary Methods (Text S1).
Our basic model assumes that there are two mutually exclusive categories of genes. With probability Π0 there is no eQTN in the cis-candidate region, and with probability Π1 = 1−Π0 there is a single eQTN. Then the likelihood of the expression data at gene k is
(4) |
where denotes the probability of the expression data Yk given that there is no eQTN in gene k and denotes the probability of the expression data given that there is exactly one eQTN. Note that our model allows for at most one eQTN per gene. If in fact there is more than eQTN, our model will usually assign the signal to the strongest of these. In practice, we see little variation in average effect size as a function of location, so this modeling simplification is unlikely to seriously distort the results.
Given that there is a single eQTN in gene k, the probability of the observed expression data, , can be written as
(5) |
where is the probability of the expression data given that SNP j is an eQTN, and πjk is the prior probability that SNP j is an eQTN, given that exactly one SNP in gene k is an eQTN.
A key feature of the hierarchical model is that the probability that SNP j is an eQTN, πjk, is allowed to depend on the physical location of SNP j relative to one or more “anchor” points, and other relevant annotations (see Text S1). Suppose that we consider L different kinds of annotation, and let the indicator δjkl equal 1 if SNP j at gene k has the lth annotation, and equal 0 otherwise. Then define
(6) |
where Λ = (λ1,…,λL) is a vector of annotation effect parameters. We use a logistic model to relate πjk to these annotation indicators, namely,
(7) |
As detailed in the Supplementary Methods (Text S1), we parameterized the effect of distance from the anchor locations using a series of discrete bins that represent absolute physical distance from the relevant anchor. The bins nearest to the anchor are 1 kb wide, and increase in width to 10 kb and finally 100 kb with increasing distance from the anchor. For the two-anchor models, each SNP belongs to two position bins, each of which indicates distance from one anchor.
Likelihood for the Hierarchical Model
Substituting the above expressions for into (4), the likelihood for the hierarchical model is
(8) |
(9) |
where Θ denotes the model parameters and BFjk is the BF from the Bayesian regression (3). To be explicit, the model parameters Θ include the annotation parameters Λ, the proportion Π0 and other parameters related to the Bayes factor computation (see Text S1). The likelihood of the entire data set is the product of (9) across all K genes. We fit the hierarchical model by maximizing the log-likelihood
(10) |
with respect to the model parameters Θ. (Note that the first term, involving does not depend on Θ, and so need not be evaluated.)
Accounting for the Effects of SNPs in Probes
Since undetected SNPs in the probe sequence sometimes generate eQTLs, the results that we report include a modification to account for this effect. We used the 634 genes that have a known SNP in the probe region as training data to help parameterize the model. We assume that these represent ∼1/3 of all probes with common SNPs [25].
Suppose that with probability there is a gene inside the probe sequence (this is set to 1 for the training data), and suppose that when there is a SNP in the probe, there is a probability Πs that this generates a spurious signal. Then let be the probability of a spurious signal. We consider that we are only interested in real signals if there is no spurious signal, so we write the probability of the data as
(11) |
where the first term is the likelihood when there is no spurious signal (as in Equation 4), and where the second term gives the likelihood () when there is a spurious signal.
Likelihood Maximization
To maximize [10] we used an iterative strategy based on a point-by-point golden maximization strategy [46]. To speed convergence of the maximization process, we initialized the parameters using naive estimates of the λs based on the logarithm of the odds ratio computed assuming Π0 = 0.
Posterior Probabilities
Once the likelihood has been maximized, we can compute the posterior probability of a given SNP j to be an eQTN for gene k. In the case without spurious signals this is
(12) |
and the general version is given in the Supplementary Methods (Text S1).
Sequence Conservation and Transcription Factor Binding
To compute the average sequence conservation as a function of position for Figure 4B, we estimated the average number of substitutions per site across the phylogeny of seven mammalian species (human, chimpanzee, macaque, mouse, rat, dog, and cow), using data and alignments from the UCSC browser. This was done for the main set of 11,446 genes analyzed in this paper. For each gene, 5 kb on each side of the TSS (and separately for the TES) was split into non-overlapping 50-bp bins. We then concatenated all the sites across all genes that lay in the same bin. After excluding sites in coding exons we estimated the average number of substitutions at each site using baseml, a program in the PAML package [47].
We obtained results on transcription factor binding density using ChIP-chip data collected by the ENCODE project (4). We used data for eight transcription factors that showed large numbers of binding fragments at a 1% false discovery rate in the ENCODE study. The left-hand panel of Figure 4C is essentially a replotting of data presented in Figure 5 of (4), while the right-hand panel shows analogous data plotted with respect to the TES.
Software Availability
The methods reported here are implemented in the package eQTNMiner, which is available from JBV on request.
Supporting Information
Acknowledgments
We thank Abraham Palmer, Marcelo Nobrega, and Kevin Bullaughey, Graham Coop and other members of the Pritchard, Przeworski and Stephens groups for discussions and comments, and the anonymous reviewers for extensive comments on the manuscript.
Footnotes
The authors have declared that no competing interests exist.
This work was supported by grants from the National Institutes of Health GM077959 to YG, HG02585-01 to MS, and HG002772 to JKP and by a postdoctoral fellowship from l'Institut National de la Recherche Agronomique to JBV. JKP is an investigator of the Howard Hughes Medical Institute.
References
- 1.Knight J. Regulatory polymorphisms underlying complex disease traits. Journal of Molecular Medicine. 2005;83:97–109. doi: 10.1007/s00109-004-0603-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kleinjan D, van Heyningen V. Long-Range Control of Gene Ex-pression: Emerging Mechanisms and Disruption in Disease. The American Journal of Human Genetics. 2005;76:8–32. doi: 10.1086/426833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wray G. The evolutionary significance of cis-regulatory mutations. Nat Rev Genet. 2007;8:206–216. doi: 10.1038/nrg2063. [DOI] [PubMed] [Google Scholar]
- 4.ENCODE Project Consortium. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447:799–816. doi: 10.1038/nature05874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kim T, Abdullaev Z, Smith A, Ching K, Loukinov D, et al. Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome. Cell. 2007;128:1231–1245. doi: 10.1016/j.cell.2006.12.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Pennacchio L, Ahituv N, Moses A, Prabhakar S, Nobrega M, et al. In vivo enhancer analysis of human conserved non-coding sequences. Nature. 2006;444:499–502. doi: 10.1038/nature05295. [DOI] [PubMed] [Google Scholar]
- 7.Tompa M, Li N, Bailey T, Church G, De Moor B, et al. Assessing computational tools for the discovery of transcription factor binding sites. Nature Biotechnology. 2005;23:137–144. doi: 10.1038/nbt1053. [DOI] [PubMed] [Google Scholar]
- 8.Blanchette M, Bataille A, Chen X, Poitras C, Laganiere J, et al. Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression. Genome Res. 2006;16:656–668. doi: 10.1101/gr.4866006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Xie X, Mikkelsen T, Gnirke A, Lindblad-Toh K, Kellis M, et al. Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites. Proc Natl Acad Sci U S A. 2007;104:7145–50. doi: 10.1073/pnas.0701811104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gilad Y, Rifkin S, Pritchard J. Revealing the architecture of gene regulation: the promise of eQTL studies. Trends in Genetics. 2008 doi: 10.1016/j.tig.2008.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cheung V, Conlin L, Weber T, Arcaro M, Jen K, et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet. 2003;33:422–425. doi: 10.1038/ng1094. doi:10.1038/ng1094. [DOI] [PubMed] [Google Scholar]
- 12.Dixon A, Liang L, Moffatt M, Chen W, Heath S, et al. A genome-wide association study of global gene expression. Nature Genetics. 2007;39:1202–1207. doi: 10.1038/ng2109. [DOI] [PubMed] [Google Scholar]
- 13.Göring H, Curran J, Johnson M, Dyer T, Charlesworth J, et al. Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nature Genetics. 2007;39:1208–1216. doi: 10.1038/ng2119. [DOI] [PubMed] [Google Scholar]
- 14.Emilsson V, Thorleifsson G, Zhang B, Leonardson A, Zink F, et al. Genetics of gene expression and its effect on disease. Nature. 2008;452:423–428. doi: 10.1038/nature06758. [DOI] [PubMed] [Google Scholar]
- 15.Brem R, Yvert G, Clinton R, Kruglyak L. Genetic Dissection of Transcriptional Regulation in Budding Yeast. Science. 2002;296:752. doi: 10.1126/science.1069516. [DOI] [PubMed] [Google Scholar]
- 16.Schadt E, Monks S, Drake T, Lusis A, Che N, et al. Genetics of gene expression surveyed in maize, mouse and man. Nature. 2003;422:297–302. doi: 10.1038/nature01434. [DOI] [PubMed] [Google Scholar]
- 17.Morley M, Molony C, Weber T, Devlin J, Ewens K, et al. Genetic analysis of genome-wide variation in human gene expression. Nature. 2004;430:743–747. doi: 10.1038/nature02797. doi:10.1038/nature02797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Cheung V, Spielman R, Ewens K, Weber T, Morley M, et al. Mapping determinants of human gene expression by regional and genome-wide association. Nature. 2005;437:1365–1369. doi: 10.1038/nature04244. doi:10.1038/nature04244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Stranger B, Forrest M, Dunning M, Ingle C, Beazley C, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007;315:848–853. doi: 10.1126/science.1136678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Stranger B, Nica A, Forrest M, Dimas A, Bird C, et al. Population genomics of human gene expression. Nature Genetics. 2007;39:1217–1224. doi: 10.1038/ng2142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kwan T, Benovoy D, Dias C, Gurd S, Provencher C, et al. Genome-wide analysis of transcript isoform variation in humans. Nat Genet. 2008;40:225–231. doi: 10.1038/ng.2007.57. [DOI] [PubMed] [Google Scholar]
- 22.Ronald J, Brem R, Whittle J, Kruglyak L. Local regulatory variation in Saccharomyces cerevisiae. PLoS Genet. 2005;1:e25. doi: 10.1371/journal.pgen.0010025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.GuhaThakurta D, Xie T, Anand M, Edwards S, Li G, et al. Cis-regulatory variations: A study of SNPs around genes showing cis-linkage in segregating mouse populations. BMC Genomics. 2006;7:235. doi: 10.1186/1471-2164-7-235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299–1320. doi: 10.1038/nature04226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449:851–861. doi: 10.1038/nature06258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Spielman R, Bastone L, Burdick J, Morley M, Ewens W, et al. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet. 2007;39:226–231. doi: 10.1038/ng1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Idaghdour Y, Storey J, Jadallah S, Gibson G. A genome-wide gene expression signature of environmental geography in leukocytes of Moroccan Amazighs. PLoS Genet. 2008;4:e1000052. doi: 10.1371/journal.pgen.1000052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: a pratical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B. 1995;57:289–300. [Google Scholar]
- 29.Servin B, Stephens M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 2007;3:e114. doi: 10.1371/journal.pgen.0030114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Alberts R, Terpstra P, Li Y, Breitling R, Nap J, et al. Sequence Polymorphisms Cause Many False cis eQTLs. PLoS ONE. 2007;2:e622. doi: 10.1371/journal.pone.0000622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Saxonov S, Berg P, Brutlag D. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proceedings of the National Academy of Sciences. 2006;103:1412–1417. doi: 10.1073/pnas.0510310103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lemon B, Tjian R. Orchestrated response: a symphony of tran-scription factors for gene control. Genes & Development. 2000;14:2551–2569. doi: 10.1101/gad.831000. [DOI] [PubMed] [Google Scholar]
- 33.White R. Gene transcription: mechanims and control. Blackwell Science 2001 [Google Scholar]
- 34.Wray G, Hahn M, Abouheif E, Balhoff J, Pizer M, et al. The Evolution of Transcriptional Regulation in Eukaryotes. Molecular Biology and Evolution. 2003;20:1377–1419. doi: 10.1093/molbev/msg140. [DOI] [PubMed] [Google Scholar]
- 35.Maston G, Evans S, Green M. Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet. 2006;7:29–59. doi: 10.1146/annurev.genom.7.080505.115623. [DOI] [PubMed] [Google Scholar]
- 36.Chabot A, Shrit R, Blekhman R, Gilad Y. Using Reporter Gene Assays to Identify cis Regulatory Differences Between Humans and Chimpanzees. Genetics. 2007;176:2069. doi: 10.1534/genetics.107.073429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Wang Y, Liu C, Storey J, Tibshirani R, Herschlag D, et al. Precision and functional specificity in mRNA decay. Proceedings of the National Academy of Sciences. 2002;99:5860. doi: 10.1073/pnas.092538799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Bevilacqua A, Ceriani M, Capaccioli S, Nicolin A. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. Journal of Cellular Physiology. 2003;195:356–372. doi: 10.1002/jcp.10272. [DOI] [PubMed] [Google Scholar]
- 39.Meyer S, Temme C, Wahle E. Messenger RNA Turnover in Eukaryotes Pathways and Enzymes. Critical Reviews in Biochemistry and Molecular Biology. 2004;39:197–216. doi: 10.1080/10409230490513991. [DOI] [PubMed] [Google Scholar]
- 40.Carthew R. Gene regulation by microRNAs. Current Opinion in Genetics & Development. 2006;16:203–208. doi: 10.1016/j.gde.2006.02.012. [DOI] [PubMed] [Google Scholar]
- 41.Eberle A, Stalder L, Mathys H, Orozco R, Muhlemann O. Post-transcriptional gene regulation by spatial rearrangement of the 3′ untranslated region. PLoS Biol. 2008;6:e92. doi: 10.1371/journal.pbio.0060092. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Storey J, Madeoy J, Strout J, Wurfel M, Ronald J, et al. Gene-expression variation within and among human populations. Am J Hum Genet. 2007;80:502–9. doi: 10.1086/512017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Kent WJ. BLAT–the BLAST-like alignment tool. Genome Res. 2002;12:656–64. doi: 10.1101/gr.229202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Pruitt K, Tatusova T, Maglott D. NCBI reference sequences (Ref-Seq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Research. 2007;35:D61–D65. doi: 10.1093/nar/gkl842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Wakaguri H, Yamashita R, Suzuki Y, Sugano S, Nakai K. DBTSS: database of transcription start sites, progress report 2008. Nucleic Acids Res. 2007 doi: 10.1093/nar/gkm901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Brent R. Algorithms for Minimization without Derivatives. New Jersey: Prentice Hall; 1973. [Google Scholar]
- 47.Yang Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol. 2007;24:1586–1591. doi: 10.1093/molbev/msm088. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.